Search Result "D1 receptor"
A New Approach for Treatment of Hypertension: Modifying D1 Dopamine Receptor Function
Journal: Cardiovascular & Hematological Agents in Medicinal Chemistry
Volume: 4 Issue: 4 Year: 2006 Page: 369-377
Author(s): Chunyu Zeng, Robin A. Felder, Pedro A. Jose
Advances in Dopamine D1 Receptor Ligands for Neurotherapeutics
Journal: Current Topics in Medicinal Chemistry
Volume: 19 Issue: 16 Year: 2019 Page: 1365-1380
Author(s): Daniel E. Felsing,Manish K. Jain,John A. Allen
Dopamine D1 Receptors, Regulation of Gene Expression in the Brain, and Neurodegeneration
Journal: CNS & Neurological Disorders - Drug Targets
Volume: 9 Issue: 5 Year: 2010 Page: 526-538
Author(s): Jean Lud Cadet, Subramaniam Jayanthi, Michael T. McCoy, Genevieve Beauvais, Ning Sheng Cai
Ibopamine Stimulates α-Adrenergic Receptors and D1 Dopaminergic Receptors in the Eye
Journal: Current Drug Therapy
Volume: 2 Issue: 2 Year: 2007 Page: 127-132
Author(s): Italo Giuffre
Prime Time for G-Protein-Coupled Receptor Heteromers as Therapeutic Targets for CNS disorders: The Dopamine D1-D3 Receptor Heteromer
Journal: CNS & Neurological Disorders - Drug Targets
Volume: 9 Issue: 5 Year: 2010 Page: 596-600
Author(s): Sergi Ferre, Carmen Lluis, Jose Luis Lanciego, Rafael Franco
The NMDA/D1 Receptor Complex as a New Target in Drug Development
Journal: Current Topics in Medicinal Chemistry
Volume: 6 Issue: 8 Year: 2006 Page: 801-808
Author(s): Cristina Missale, Chiara Fiorentini, Chiara Busi, Ginetta Collo, P. F. Spano
Artificial Neural Network (ANN) Based Modelling for D1 Like and D2 Like Dopamine Receptor Affinity and Selectivity
Journal: Medicinal Chemistry
Volume: 6 Issue: 5 Year: 2010 Page: 259-270
Author(s): Dana A. Karolidis, Snezana Agatonovic-Kustrin, David W. Morton
Frontal Lobe Synaptic Plasticity in Development and Disease: Modulation by the Dopamine D1 Receptor
Journal: Current Pharmaceutical Design
Volume: 20 Issue: 32 Year: 2014 Page: 5194-5201
Author(s): Lynn D. Selemon
D1 and Functionally Selective Dopamine Agonists as Neuroprotective Agents in Parkinsons Disease
Journal: CNS & Neurological Disorders - Drug Targets
Volume: 5 Issue: 3 Year: 2006 Page: 345-353
Author(s): M. M. Lewis, X. Huang, D. E. Nichols, R. B. Mailman
Rationale and Development of Tavapadon, a D1/D5-Selective PartialDopamine Agonist for the Treatment of Parkinsonâs Disease
Journal: CNS & Neurological Disorders - Drug Targets
Volume: 23 Issue: 4 Year: 2024 Page: 476-487
Author(s):